Wyss Institute selected to develop biologically engineered broad-spectrum antimicrobial therapeutic

Low-Res_Darpa Shield Team Photo-02154

Source: Wyss Institute at Harvard University

The Wyss Institute for Biologically Inspired Engineering at Harvard University received a contract for up to $12M from the new SHIELD program which aims to develop a prophylactic treatment that can rapidly clear multiple bloodborne bacterial and fungal pathogens.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE